Chiome Bioscience Inc. reported non-consolidated financial results for the nine months ended September 30, 2017. For the period, the company's net sales were JPY 186 million against JPY 175 million for the same period a year ago. Operating loss was JPY 574 million against JPY 827 million for the same period a year ago. Ordinary loss was JPY 575 million against JPY 827 million for the same period a year ago. Loss before income taxes was JPY 572.777 million against JPY 962.138 million for the same period a year ago. Net loss was JPY 574 million against JPY 964 million for the same period a year ago. Net loss per Share was JPY 21.92 against JPY 43.24 a year ago.